Cannabis Bioscience International Holdings (CBIH) Interest Coverage Ratio (2022 - 2026)
Cannabis Bioscience International Holdings' (CBIH) quarterly Interest Coverage Ratio came in at 8.65 in Q1 2026, down 50.49% year-on-year from 17.48 in Q1 2025, and up 70.84% quarter-over-quarter from 29.68 in Q4 2025.
Cannabis Bioscience International Holdings (CBIH) Interest Coverage Ratio (2022 - 2026) Analysis & Trends
Cannabis Bioscience International Holdings has disclosed Interest Coverage Ratio across 5 years of filings, most recently posting 8.65 for Q1 2026.
- Interest Coverage Ratio for Q1 2026 came in at 8.65, down 50.49% year-over-year; the trailing twelve-month figure through Feb 2026 was 2.97 (down 113.54% YoY), and the FY2025 annual result was 3.09, up 93.0% from the prior year.
- Interest Coverage Ratio came in at 8.65 for Q1 2026 at Cannabis Bioscience International Holdings, up from 29.68 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 0.62 in Q2 2024 to a low of 227.94 in Q2 2023.
- The 5-year median for Interest Coverage Ratio is 6.85 (2024), against an average of 28.95.
- Across the five-year window, Interest Coverage Ratio surged 100.27% in 2024 and tumbled 333.15% in 2025, its largest moves.
- Cannabis Bioscience International Holdings' Interest Coverage Ratio stood at 5.06 in 2022, then plunged by 597.9% to 35.32 in 2023, then soared by 80.6% to 6.85 in 2024, then sank by 333.15% to 29.68 in 2025, then soared by 70.84% to 8.65 in 2026.
- The last three Interest Coverage Ratio figures came in at 8.65 (Q1 2026), 29.68 (Q4 2025), and 4.31 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 13.44 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 108.60 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 5.39 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.31 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 16.72 |
| 10 | Cannabis Bioscience International Holdings | - | - | 8,160.00 | -8.65 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -8.65 |
| Nov 30, 2025 | -29.68 |
| Aug 31, 2025 | -4.31 |
| May 31, 2025 | -1.31 |
| Feb 28, 2025 | -5.75 |
| Nov 30, 2024 | -6.85 |
| Aug 31, 2024 | -41.73 |
| May 31, 2024 | 0.62 |
| Feb 29, 2024 | -3.25 |
| Aug 31, 2023 | -35.32 |
| May 31, 2023 | -227.94 |
| Feb 28, 2023 | -7.16 |
| Nov 30, 2022 | -5.06 |